ACTI — Active Biotech AB publ Balance Sheet
0.000.00%
- SEK113.48m
- SEK48.48m
Annual balance sheet for Active Biotech AB publ, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 53.1 | 41.8 | 36.2 | 27.4 | 65.1 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.19 | 0.947 | 1.25 | 9.5 | 2.5 |
| Prepaid Expenses | |||||
| Total Current Assets | 55.9 | 44.1 | 38.7 | 39.2 | 67.6 |
| Net Property, Plant And Equipment | 0.945 | 6.26 | 4.72 | 3.35 | 2 |
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Total Assets | 56.8 | 51 | 44 | 43.2 | 70.2 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 9.9 | 12.1 | 10.4 | 8.91 | 14.5 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 10.1 | 16.5 | 13.4 | 10.4 | 14.6 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 46.7 | 34.5 | 30.7 | 32.7 | 55.6 |
| Total Liabilities & Shareholders' Equity | 56.8 | 51 | 44 | 43.2 | 70.2 |
| Total Common Shares Outstanding |